Home › Non-Small Cell Lung Cancer › Illinois › Aurora
Non-Small Cell Lung Cancer clinical trials in Aurora, IL
11 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Rush-Copley Medical Center, Aurora
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RecruitingPhase 2
- Rush-Copley Medical Center, Aurora
- Rush-Copley Healthcare Center, Yorkville · 11 mi away
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
RecruitingPhase 2
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RecruitingPhase 3
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RecruitingPhase 3
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Advocate Outpatient Center - Aurora, Aurora
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Advocate Outpatient Center - Aurora, Aurora
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- Rush-Copley Healthcare Center, Yorkville · 11 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Other studies in Aurora
- Lung Cancer11 studies
- Prostate Cancer9 studies
- Melanoma7 studies
- Breast Cancer7 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Ovarian Cancer5 studies
- Cancer (all types)4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Hypopharyngeal Cancer4 studies
- Laryngeal Cancer4 studies
- Oral Cancer4 studies
- Acute Myeloid Leukemia4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.